Home » Topics » BioWorld Science

BioWorld Science
RSS

Rat model for PD using AAV-induced overexpression of E46K-like alphaSYN mutants

Nov. 19, 2021

Anti-PD-L1 IGM-7354 shows promise for cancer immunotherapy

Nov. 19, 2021

Emultech and Osteo-Pharma establish Bone-Tech joint venture for osteoarthritis

Nov. 18, 2021

CoImmune enters research collaboration with Yeda Research and Development on SIN technology

Nov. 18, 2021

Abintus to use Memorial Sloan's 1XX technology with CAR-X products

Nov. 18, 2021

TOTUM-854 prevents the development of experimental arterial hypertension

Nov. 18, 2021

Novel acute lung injury murine model unveils neuronal damage

Nov. 18, 2021

Shanghai Licheng Biotechnology divulges CLRN3-targeting nucleic acids

Nov. 18, 2021

Betta Pharmaceuticals identifies PTPN11 inhibitors

Nov. 18, 2021

GNT Biotech & Medicals presents new HDAC inhibitors

Nov. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...